Migraine: Symptoms, Treatment & Follow-Up

Migraine is a recurrent primary headache disorder driven by genetically influenced brain excitability and trigeminovascular activation—producing inflammatory signalling around meningeal nociceptors without requiring infection or mass lesion to explain each attack. Attacks vary from a few yearly to near-daily chronic migraine patterns when chronification and medication-overuse headache supervene.

Clinicians stratify care by phenotype (with vs without aura, vestibular predominant, menstrual-linked), disability, cardiovascular risk, pregnancy intent, and psychiatric comorbidity. Ward and urgent-care nurses anchor safety by distinguishing evolving migraine disability from secondary emergencies discussed under national headache triage literature summarized alongside other phenotypes in the clinical guide to headache disorders.

Effective programmes coordinate timing of acute pharmacotherapy, antiemetic support, preventive titration, adverse-effect surveillance, and clear thresholds for neurology or ED referral—rather than episodic PRN analgesia alone.

ICHD-3 defines migraine subtypes by aura presence, aura quality, chronicity, and accompanying cranial autonomic features—documentation should capture duration bands, lateralization, photophonophobia intensity, and gastrointestinal accompaniments so specialists reproduce phenotype decisions remotely.

↔On a small screen, swipe or scroll sideways to see the full table.

Classic attacks produce unilateral pulsatile pain worsened by bending or stairs, with gastrointestinal misery and inability to tolerate bright lights or sound—many patients retreat to dark quiet rooms. Aura symptoms march slowly as shimmering scotomata, sensory hemibody tingling, or dysphasia, then resolve before or during headache except in unusual variants.

Vestibular migraine may dominate with vertigo and imbalance yet lack throbbing pain initially—falls precautions matter. Menstrual migraine clusters link to estrogen withdrawal windows.

Atypical cues demanding documentation upgrades include aura lasting beyond roughly one hour without improvement, abrupt “worst-ever” headache, progressive visual failure distinct from shimmering fortifications, or systemic infection markers—these shift probability toward secondary diagnoses despite migraine history.

Sensory overlaps nurses chart precisely

• Photophobia versus true visual field cut—compare with vision changes descriptors.
• Nausea severity guiding IV antiemetics versus oral agents.
• Speech disturbance distinguishing migraine aura from acute cerebrovascular aphasia—capture onset clock and word-finding examples.

Migraine inherits polygenic vulnerability interacting with estrogen fluctuations, sleep fragmentation, fasting, alcohol (especially red wine), caffeine withdrawal, stress let-down, sensory overload, and weather shifts—not every trigger is modifiable, yet nursing reviews identify additive contributors during flare clusters.

Psychiatric and lifestyle intersections

• Anxiety and depression correlate with attack frequency and pain-related disability—coordinate psychology referrals without implying migraine is purely psychiatric.
• Obesity and snoring patterns intersect with chronification—document weight trends when programmes track preventive readiness.
• Medication-overuse from frequent OTC combinations sensitises pain pathways—capture tablet counts honestly.

Migraine diagnosis remains clinical when historical criteria align and neurologic examination is normal between attacks—no mandatory imaging for uncomplicated recurrent phenotypes. Structured neurological assessment proves absence of persistent focality during uncertain encounters.

Investigations when red flags accumulate

• Non-contrast CT addresses acute thunderclap pathways; MRI adds posterior fossa resolution or venous sinus evaluation when posterior circulation stroke or cerebral venous thrombosis remains plausible.
• Brain MRI supports demyelinating mimic evaluation when optic neuritis-style pain overlaps sensory phenomena.
• Lumbar puncture follows institutional algorithms after negative CT yet subarachnoid hemorrhage suspicion persists—assist with positioning, opening pressure capture, and observation scheduling.

Seizure mimic suspicion prompts EEG coordination via neurology—overlap exists between cortical spreading depression aura and focal epileptic activity described in the epilepsy overview.

1. Quantify onset: record time-zero, peak-intensity trajectory, aura timeline, prior attack comparator.
2. Vitals & pregnancy: blood pressure, glucose when indicated, pregnancy status guiding drug safety.
3. Neuro screen: speech, gaze, limb power, cerebellar checks—repeat after antiemetics if sedation risk.
4. Acute therapy lane: if migraine-native pattern without red flags, deliver early oral ibuprofen or prescribed triptan plus metoclopramide / ondansetron per chart.
5. Failure rescue: persistent vomiting—switch to parenteral antiemetics; escalating deficits—stop migraine pathway and escalate imaging.

↔On a small screen, swipe or scroll sideways to see the full table.

Acute abortive therapy

Early combination of NSAIDs with oral serotonin 5-HT_1B/1D agonists—commonly sumatriptan or rizatriptan—matches contemporary consensus summaries integrating traditional triptans alongside newer gepants where formulary permits; verify cardiovascular contraindications, serotonin drug stacks, and prior ergot exposure.

Add antiemetics when gastric stasis threatens absorption; acetaminophen suits NSAID contraindication contexts though weaker monotherapy for severe migraine.

Preventive (prophylactic) therapy

When disabling attacks exceed roughly four monthly or chronic migraine emerges, initiate guideline-directed prevention—beta-adrenergic blockade (propranolol), anticonvulsant modulation (topiramate), or tricyclic serotonin-norepinephrine modulation (amitriptyline) remain foundational oral ladders alongside newer monoclonal antibodies targeting CGRP peptides administered under specialist governance.

Interventional & advanced adjuncts

OnabotulinumtoxinA every twelve weeks benefits carefully selected chronic migraine cohorts under NICE TA260 criteria context in UK funding frameworks—appointments hinge on headache-day diaries proving persistence despite oral prevention.

Population specifics

• Pregnancy/lactation: triptan decisions rest with obstetric-pharmacy dyads—many pathways prioritise metoclopramide plus acetaminophen early.
• Pediatrics: shorter attacks with abdominal pain prominence—align dosing with paediatric neurology.
• Older adults: scrutinise coronary disease before triptans; watch anticholinergic burden with amitriptyline.

• Monitoring cadence: chart BP/pulse after triptans and beta-blocker initiation; weight and cognition with topiramate; QT considerations if combining amitriptyline with other QT prolongers.
• Follow-up timing: preventive medication reviews typically occur 8–12 weeks after achieving therapeutic dose unless adverse effects surface sooner.
• Medication interaction vigilance: serotonin syndrome rarity remains teachable point when SSRIs stack with triptans—document pharmacy counselling flags.
• Treatment failure definition: escalating ED attendance, opioid reliance, or absent functional improvement despite adherence warrants tertiary headache referral—not escalating PRN opioids.

Bedside monitoring checklist

• Hydration, electrolytes when ketotic vomiting prolonged.
• Neurological trending folders showing aura clocks versus deficit persistence.
• Functional markers—ambulation distance, screen tolerance—not numeric pain alone.

Debilitating attacks precipitate occupational disability, mood deterioration, and unnecessary ionizing radiation if clinicians repeatedly image stereotyped benign phenotypes—yet under-imaging when thunderclap features hide remains equally harmful.

• Status migrainosus (prolonged severe attack >72 hours) risks dehydration and electrolyte derangements.
• Persistent aura without infarction requires vascular exclusion.
• Medication-overuse headache perpetuates chronic daily pain until detox strategies succeed.

Preventive gains blend pharmacologic titration with trigger hygiene tailored to comorbidity—regular meals, caffeine taper discipline, sleep regularity, moderate exercise, and migraine diary analytics informing consultants.

Behavioural therapies (CBT, biofeedback) augment pharmacotherapy adherence especially when anxiety amplifies pain catastrophising.

Many patients experience fluctuating severity across reproductive life stages—menopause sometimes attenuates hormonally linked attacks while chronification risk persists with obesity or medication-overuse patterns.

Transparent counselling avoids guaranteeing cure while emphasising that structured preventive plans frequently halve headache-day burden when adhered to and routinely audited.

Nurses translate guideline jargon into teach-back scripts: demonstrate correct timing for acute dosing, coach antiemetic administration prior to oral triptans when vomiting dominates, and rehearse aura vocabulary so telemedicine clinicians grasp tempo distinctions.

Documentation bridges shifts—SBAR handoffs should carry aura onset-to-resolution timeline, last successful abortive regimen, cardiovascular screening answers, pregnancy possibilities, and objective neuro observations whenever unsure.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching, and cloze completion on the topic of migraine aura clocks, triptan stewardship, stroke mimic vigilance, antiemetic sequencing, preventive counselling, and medication-overuse surveillance—mirroring Clinical Judgment Measurement Model moves from cue recognition through outcome evaluation.